Package 72789-301-90

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 72789-301-90
Digits Only 7278930190
Product NDC 72789-301
Product ID 72789-301_4bae463f-cd7d-3ffd-e063-6294a90adb7a
Description

90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-301-90)

Marketing

Marketing Status
Marketed Since 2022-02-22
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4bae463f-cd7d-3ffd-e063-6294a90adb7a", "openfda": {"upc": ["0372789301907"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["ae3bcdf7-d7f3-4f07-8113-af08af20a0d4"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-301-90)", "package_ndc": "72789-301-90", "marketing_start_date": "20220222"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "72789-301_4bae463f-cd7d-3ffd-e063-6294a90adb7a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "72789-301", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20181108", "listing_expiration_date": "20271231"}